PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative ...

When Lori Stryer and David Bolinger tell people about RIVR Media's new podcast, "Living Our Best with Memory Loss," they keep hearing the same thing: I know someone with memory loss. "There are so ...

Study into intimate partner violence finds strangulation and head impacts increase risk of long-term memory loss and cognitive disabilities ...

In our anti-aging obsessed culture, it's easy to fall into the trap of believing that aging is inherently bad. But, according to new research conducted at Yale University, those very beliefs can have ...

Memory representations are fundamental to human cognition, yet their integrity can be compromised with advancing age. Recent research has elucidated complex molecular and circuit-level mechanisms ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. New research found that taking a daily multivitamin ...

In a new study, a molecule identified and synthesized by UCLA Health researchers was shown to restore cognifitive functions in mice with Alzheimer’s disease symptoms. The compound effectively ...

PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (CGTX) (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat ...